IL2RG and neoplasm: The design of our DoxFILN is based on our finding that only TNBC patients with high intratumoral transcription of both IL15 and IL2RG have a favorable prognosis than those with low transcription of the two genes, which indicates that effective anti‐tumor immune surveillance requires the infiltration and activation of effector cells.